Search for: "LUPIN, LTD."
Results 101 - 120
of 131
Sorted by Relevance
|
Sort by Date
28 Mar 2014, 5:33 pm
.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
24 Sep 2010, 1:15 pm
Lupin Ltd., 499 F.3d 1293 (Fed. [read post]
27 May 2010, 3:20 am
Lupin Ltd. [read post]
11 Nov 2017, 11:00 am
Lupin Ltd., 780 F.3d1337, 1351 (Fed. [read post]
3 Sep 2015, 11:36 am
Lupin Ltd., 684 F.3d 1253, 1260 (Fed. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
2 Sep 2010, 10:51 am
Lupin, Ltd., 499 F.3d 1293 (Fed. [read post]
22 Apr 2014, 11:51 am
Lupin Ltd., 2011 WL 1897322 (D. [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously confirms that… [read post]
25 Jul 2008, 2:11 am
Lupin, Ltd., 499 F.3d 1293, 1301 (Fed. [read post]
29 Dec 2010, 2:57 am
Pfizer Ltd (Kluwer Patent Blog) Boniva (Ibandronate) – US: Roche dodges Cobalt invalidity contention in Boniva patent suit (Patent Docs) Boniva (Ibandronate) – US: Hoffman-La Roche files patent infringement suit against Mutual Pharmaceutical Company following Para IV certification filing (Patent Docs) Botox (Botulinum) – EU: General Court confirms declarations of invalidity of BOTOLIST and BOTOCYL filed by Allergan: T-345/08 and T-357-08 (Class 46) Detrol (Tolterodine)… [read post]
6 May 2017, 10:11 am
Lupin, Ltd., 676 F.3d 1316,1321 (Fed. [read post]
11 Mar 2013, 10:18 pm
Next it was Aparajita’s turn to come up with an incisive case review of Lupin Ltd. v. [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier Foundation), (IAM), (IAM), (IPBiz),… [read post]
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D Michigan rules… [read post]
6 Jan 2009, 9:14 am
Now, how the phrase “tied to a particular machine” will be applied to software patents. (5) Lupin Ltd. v. [read post]
9 Dec 2009, 3:59 pm
Ltd. et al. v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP Factor)… [read post]
